Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Spinal Cord Injuries 1

Interventions

Gemcitabine 25Cisplatin 19pembrolizumab 11avelumab 10Nivolumab 7Mitomycin 6Carboplatin 6apaziquone 5Paclitaxel 5Vinblastine 4Methotrexate 4Doxorubicin 4Docetaxel 4BCG Vaccine 4vofatamab 3durvalumab 3atezolizumab 3Sunitinib 3Standard of Care 3Sorafenib 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Lapatinib 3Cystectomy 3B701 protein, Human herpesvirus 6 3valrubicin 2rucaparib 2enfortumab vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Urination × Clear all
NCT02538809 2025-02-13

Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

Swiss Paraplegic Research, Nottwil

Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Spinal Cord Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡